NIH Instagram

View this post on Instagram

With improved rates of survival in childhood illnesses in the U.S., individuals are living longer with one or more chronic conditions. To meet the needs of diverse populations with chronic conditions or disabilities as they transition from pediatric to adult-centric services, barriers to successful health care transition (HCT), methods and measures for defining HCT, and the identification of promising practices must be better understood. On 9/30-10/1, #NIH will bring together experts representing a broad range of pediatric diseases and conditions to discuss the current state of health care transition research. See the link in our bio to register for the free virtual workshop. The workshop is part of the NIH Pediatric Research Consortium, or N-PeRC. @nichd_nih @nationalcancerinstitute #nihHEALinitative #OBSSR #VirtualWorkshop #PediatricResearch #Healthcare https://bit.ly/33jnCq1

A post shared by NIH (@nihgov) on Sep 21, 2020 at 4:21pm PDT

View this post on Instagram

¿Tiene preguntas sobre drogas y adicción? En este video (en español), la Dra. Nora Volkow, directora del Instituto Nacional sobre el Abuso de Drogas de Estados Unidos (NIDA por sus siglas en inglés) responde a las preguntas más frecuentes sobre tratamientos, cómo obtener ayuda y el efecto de las drogas en nuestra salud. Encuentre el enlace en nuestro bio para el video. https://bit.ly/2ZpKfYB #nida #nih #drogas #addicion #saludenespañol⠀ ⠀ Do you have questions about drugs and addiction? In this video (en español), Dr. Nora Volkow, Director of NIDA, answers frequently asked questions on treatment, how to get help, and the effect drugs have on one's health. #nida #nih #drogas #addicion #saludenespañol Follow link in bio for video. https://bit.ly/2ZpKfYB

A post shared by NIH (@nihgov) on Sep 17, 2020 at 1:13pm PDT

View this post on Instagram

#NIH is funding community engagement research efforts in areas hardest hit by #COVID19, with a goal to quickly launch outreach efforts that help reduce the impact of COVID-19 on the most vulnerable populations. Learn more about this effort led by the National Institute on Minority Health and Health Disparities and the National Heart, Lung, and Blood Institute by following the link in bio.

A post shared by NIH (@nihgov) on Sep 16, 2020 at 11:19am PDT

View this post on Instagram

NIH is pleased to announce a public-private partnership called AMP Schizophrenia, a new arm of the Accelerating Medicines Partnership (AMP). Managed by the Foundation for the National Institutes of Health, AMP aims to meet the need for early therapeutic interventions for people at risk of developing schizophrenia. AMP SCZ involves NIH, U.S. Food and Drug Administration, Foundation for the NIH, & multiple non-profit & private organizations. These partners will work toward the shared mission of discovering promising biological markers that can help identify those at risk of developing schizophrenia as early as possible, track the progression of symptoms and other outcomes and define targets for treatment development. https://bit.ly/3hvkcpm (follow link in bio) #NIH #FDA #AMP #schizophrenia

A post shared by NIH (@nihgov) on Sep 15, 2020 at 7:33am PDT

View this post on Instagram

Repost from @irpatnih: Acute myeloid leukemia (#AML) and myelodysplastic syndrome (MDS) are two types of #cancer that affect the blood-producing cells in the bone marrow. This image, captured by a #NIH researcher, shows abnormal cell development in the bone marrow of a patient enrolled in a NIH clinical trial for AML/MDS. ⠀⠀ ⠀ Blood-borne cancers like AML and MDS are often more difficult to treat than so-called "solid" tumors because they are, by nature, spread out through the entire bloodstream rather than confined to one place. Consequently, the advent of precision medicine holds particular promise for combating these rare, highly fatal cancers. A new partnership between several NIH Institutes and Centers, funded by the NIH Director's Innovation Awards, will dramatically enhance the ability of NIH researchers to scrutinize the characteristics of AML and MDS patients' cancer cells. The analyses will not only reveal potential treatment targets, but they may also permit scientists to determine why certain patients in their clinical trials benefit from a therapy while others do not or why the same cancer reappears after a seemingly successful treatment in some people but not others.⠀⠀ ⠀ You can read more about this ambitious initiative on the NIH's "I Am Intramural" blog (follow link in bio) #bloodcancerawarenessmonth #bloodcancerawareness #bloodcancerresearch #bloodcancer #science #biology #NHLBI #NIH

A post shared by NIH (@nihgov) on Sep 14, 2020 at 3:56pm PDT

View this post on Instagram

NIH has launched a series of clinical trials to evaluate the safety and effectiveness of different blood thinners in treating adults with COVID-19, particularly those experiencing life-threatening blood clotting. The trials, known as ACTIV-4, are part of NIH's Accelerating COVID-19 Therapeutic Interventions and Vaccines initiative & funded by Operation Warp Speed. They will include three categories of patients and take place at more than 100 sites around the world. Read more by following the link in bio.⠀ #NIH #NHLBI #ACTIV #COVID19 #clinicaltrials #WarpSpeed

A post shared by NIH (@nihgov) on Sep 10, 2020 at 1:32pm PDT

View this post on Instagram

How has COVID-19 impacted care for pregnant women and newborns? Find out at the free virtual workshop, COVID-19 in Pregnancy: Clinical, Research, and Therapeutics Updates, on 9/15. Hosted by NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development, the event will bring together experts in the field to share their experiences and discuss challenges, progress, and effective approaches in obstetric therapeutic research and patient care during the pandemic. Register today: https://bit.ly/3gzGJRk (Follow link in bio for a clickable link) @FDA @NICHD_NIH #NIH #COVID19 #Research #Workshop #MaternalHealth #Pregnancy #Newborns⠀ ⠀

A post shared by NIH (@nihgov) on Sep 8, 2020 at 8:07am PDT

View this post on Instagram

Save the date! On 9/21 and 9/22, the NIH Blueprint for Neuroscience Research will host a free virtual workshop, Addressing Neuroimaging Challenges Across Populations and Settings. #Neuroscience experts and technical developers will discuss challenges associated with neuroimaging across a range of populations and settings, and approaches to study design and analysis. Workshop details are available by following the link in bio. #NIH #Research #Neuroscience #Brain #Science #Research #Neuroimaging #NIHBlueprint https://bit.ly/2EdeRFn

A post shared by NIH (@nihgov) on Sep 7, 2020 at 6:15am PDT

View this post on Instagram

Did you know pan may not be the only symptom of Burning Mouth Syndrome (BMS)? ⠀ BMS is a painful, complex condition often described as a burning, scalding, or tingling feeling in the mouth that may occur every day for months or longer. Dry mouth or an altered taste in the mouth may also accompany the pain.⠀ BMS is most commonly found in adults over the age of 60. It is estimated to be about five times more frequent in women than in men.⠀ Doctors and dentists don't have a specific test for #BMS, which makes it hard to diagnose. No specific treatment works for everyone. However, a doctor can prescribe medications to help you manage the pain, dry mouth, or other symptoms.⠀ Learn more from #NIH's National Institute of Dental and Craniofacial Research https://www.nidcr.nih.gov/health-info/burning-mouth/more-info (follow link in bio)

A post shared by NIH (@nihgov) on Sep 4, 2020 at 2:54pm PDT

View this post on Instagram

NIH is awarding $129.3M for scale-up & manufacturing of 9 additional COVID-19 testing technologies as part of the second set of awards from the Rapid Acceleration of Diagnostics (RADx) initiative. These new tests have different formats & methods to allow use in many diverse settings like schools, hospitals, nursing homes, businesses or manufacturing facilities. Follow link in bio to read more.⠀ #NIH #RADx #COVID19

A post shared by NIH (@nihgov) on Sep 2, 2020 at 4:03pm PDT

View this post on Instagram

Just how much does a facial covering protect those around you from contracting the virus that causes #COVID19? Quite a bit, according to researchers who created a sophisticated mathematical model to take a more detailed look. Their model shows that even if a community universally adopted a crude cloth covering that's far less than 100 percent protective against the virus, this measure alone could significantly help to reduce deaths.⠀ Find out more on the #NIH Director's blog: https://directorsblog.nih.gov/2020/08/25/masks-save-lives/ (follow link in bio for clickable link)

A post shared by NIH (@nihgov) on Aug 26, 2020 at 5:03pm PDT

View this post on Instagram

In the latest Healthy Moments podcast from @NIDDKgov, #NIH Director Dr. Francis S. Collins explains how we're using research to find better ways to treat people with complex diseases, like inflammatory bowel disease. Visit the link in our bio for this week's episode.⠀ ⠀ #NIDDK70th #NIDDK #NIDDKgov #HealthyMoments #IBD

A post shared by NIH (@nihgov) on Aug 25, 2020 at 3:05pm PDT

View this post on Instagram

Join #NIH scientific experts on 8/24-8/25 for a virtual workshop devoted to discussing current and future practical considerations for using buprenorphine as a treatment for infants with #opioid withdrawal syndrome (#NOWS). Follow the link in bio. @nichd_nih #NIDA #NIH #Research #SubstanceUseDisorder #Infants #Science #PublicHealth #OpioidCrisis #nihHEALinitiative

A post shared by NIH (@nihgov) on Aug 24, 2020 at 8:13am PDT

View this post on Instagram

Repost from @irpatnih: The #virus that causes #COVID19 belongs to a larger family of viruses called coronaviruses, which get their name from the crown-like "spike" proteins protruding from their surfaces. The viruses use their spike proteins to infect cells, making the structures a target of intense interest from many scientists trying to develop drugs to combat the novel #coronavirus. ⠀⠀⠀ This image, courtesy of #NIH National Institute of Environmental Health Sciences scientist Mario Borgnia, shows a detailed structural image of the novel coronavirus' spike protein. These sorts of images can provide extremely useful information about how the virus infects cells and whether lab-produced antibodies or other molecules can bind to and inhibit it. ⠀⠀⠀ Producing images like this one takes a large amount of computing power. Fortunately, NIH researchers have access to #Biowulf, the world's most powerful #supercomputer solely dedicated to biomedical research. Visit the "I Am Intramural" blog to learn more about how Dr. Borgnia and other NIH scientists are utilizing Biowulf to assist the fight against COVID-19 (follow link in bio)

A post shared by NIH (@nihgov) on Aug 20, 2020 at 1:40pm PDT

View this post on Instagram

Children wearing multifocal contact lenses had slower progression of their myopia (nearsightedness), according to results from a clinical trial funded by the National Eye Institute, part of the National Institutes of Health. The findings support an option for controlling the condition, which increases the risk of cataracts, glaucoma and retinal detachment later in life.⠀ Read more by following the link in bio.⠀ In this image: The center portion of the lens corrects nearsightedness so that distance vision is clear, and it focuses light directly on the retina. The outer portion of the lens adds focusing power to bring the peripheral light rays into focus in front of the retina. Animal studies show that bringing light to focus in front of the retina cues the eye to slow growth.⠀ #NIH #NEI #myopia #nearsightedness #contactlenses #visionresearch #cataracts #glaucoma

A post shared by NIH (@nihgov) on Aug 19, 2020 at 7:13pm PDT

View this post on Instagram

For people with kidney disease, precision medicine looks beyond a one-size-fits-all approach to find treatment and prevention that works best for you. Listen to this week's Healthy Moments from @niddkgov to learn more (follow link in bio).⠀ ⠀ #NIDDK70th #NIDDK #NIDDKgov #HealthyMoments #NIH #kidneydisease #precisionmedicine

A post shared by NIH (@nihgov) on Aug 17, 2020 at 1:16pm PDT

View this post on Instagram

These docs are using science to fight #COVID19 and they're serious about winning. From left, @niaid Director Anthony Fauci, #WarpSpeed Matt Hepburn and NIH Director Francis Collins briefed reporters on Monday about the start of the Phase 3 #NIH/Moderna clinical trial for candidate vaccine mRNA-1273. https://bit.ly/30MMepW (follow link in bio to read more)

A post shared by NIH (@nihgov) on Jul 29, 2020 at 1:45pm PDT

View this post on Instagram

Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa), an NIH Common Fund program, will invest more than $58 million to advance data science, catalyze innovation and spur health discoveries across Africa, leveraging existing data and technologies to develop solutions for the continent's most pressing clinical and public health problems. DS-I Africa is accepting applications for research hubs; research training programs; ethical, legal and social implications (ELSI) research; and an open data science platform and coordinating center. Applications are due November 3 through February 8. Learn how to apply at bit.ly/nih-dsiafrica (follow link in bio for clickable link)⠀ ⠀ Image by iStock.⠀ ⠀ #NIH #dsiafrica #nihafricadata #nihdatascience #bigdata #datascience #globalhealth @niaid @nimhgov

A post shared by NIH (@nihgov) on Jul 28, 2020 at 11:38am PDT

View this post on Instagram

A Phase 3 clinical trial of an investigational vaccine for COVID-19 started today. Co-developed by NIH's @niaid and Moderna, Inc., the candidate vaccine, called mRNA-1273, is being tested for its preventive power. It's the first vaccine efficacy trial to be launched under Operation Warp Speed. The multisite trial is expected to enroll 30,000 volunteers. Learn more by tapping the link in bio. #NIH #NIAID #Vaccineresearch #COVID19 #WarpSpeed

A post shared by NIH (@nihgov) on Jul 27, 2020 at 5:53am PDT

View this post on Instagram

In order to fill the urgent need for easy, fast, point-of-care testing for COVID-19, NIH established the Rapid Acceleration of Diagnostics (#RADx) program. A paper in today's The New England Journal of Medicine (@nejm) outlines how RADx is working to address four major areas to vastly expand testing capacity by Fall 2020 and ensure testing is available to diverse, vulnerable, and underserved populations. Follow link in bio to read the paper. #NIH #COVID19

A post shared by NIH (@nihgov) on Jul 22, 2020 at 2:17pm PDT

View this post on Instagram

#NIH's #COVID19 Prevention Network tackles some of the most frequently asked questions around #COVID_19, including if COVID-19 is like the seasonal flu. No, it is not. Learn more answers to FAQs for COVID-19: https://bit.ly/3h6mBH6 (follow link in bio)

A post shared by NIH (@nihgov) on Jul 20, 2020 at 10:17am PDT

View this post on Instagram

The placenta, a key organ during #pregnancy, lacks the major molecules to manufacture cell receptors used by SARS-CoV-2 (the virus that causes COVID-19) to cause infection, according to a study by researchers at Eunice Kennedy Shriver National Institute of Child Health and Human Development (@nichd_nih). The study may help explain why the virus has rarely been found in fetuses or newborns of women with COVID-19.Read more by following the link in bio. #NIH #NICHD #placenta #COVID19

A post shared by NIH (@nihgov) on Jul 17, 2020 at 7:01am PDT

View this post on Instagram

Join us for Healthy Vision Month 2020 with the National Eye Institute, part of the #NIH!Find out how taking steps to protect your health now can help prevent vision problems in the future. Learn more: https://bit.ly/2NeY1ad (follow link in bio) #EyeHealthIsMyHealth #HealthyVisionMonth #MoreThan2020 #eyehealth #healthyvision #NEI

A post shared by NIH (@nihgov) on Jul 16, 2020 at 4:39pm PDT

View this post on Instagram

In celebration of the NIH Stimulating Peripheral Activity to Relieve Conditions (SPARC) program's efforts to bridge the divide between anatomists, physiologists, device developers and computational modelers to advance bioelectronic medicine, we want to ignite your imagination and creativity! Visit our SPARC Art Contest page to enter your original artwork and learn more: https://go.usa.gov/xf2Rz or Google 'NIH SPARC'. #NIH_SPARC #NIHCommonFund Twitter: @sparc_science⠀ #ArtContest #neuromodulation #NIH #neuroscience #BioelectronicMedicine

A post shared by NIH (@nihgov) on Jul 15, 2020 at 8:19am PDT

View this post on Instagram

A Phase 1 clinical trial investigating a possible vaccine for SARS-CoV-2, the virus that causes COVID-19, is showing promising results. The experimental vaccine was found to be well tolerated and generated immune response in healthy adult volunteers. Learn more about the ongoing study which is sponsored by NIH's National Institute of Allergy and Infectious Diseases (@niaid) and Moderna, Inc. Follow link in bio to read more. #NIH #NIAID #COVID19 #vaccineresearch #clinicaltrials

A post shared by NIH (@nihgov) on Jul 14, 2020 at 2:40pm PDT

View this post on Instagram

Through rapid mobilization and coordination of the biomedical research community, forging new programs and partnerships while leveraging existing resources, and supporting innovative research approaches, the NIH Strategic Plan for COVID-19 Research aims to accelerate the development of treatments, vaccines, and diagnostics. The plan also proposes studies on behavioral and community prevention practices and prioritizes research into the effect of COVID-19 on vulnerable and underserved populations. Follow link in bio to read more. #NIH #COVID19 #RADx #ACTIV

A post shared by NIH (@nihgov) on Jul 13, 2020 at 3:26pm PDT

View this post on Instagram

We swallow hundreds of times a day without giving it much thought, but swallowing requires a highly coordinated series of movements of the jaw and muscles in and around the tongue. A glitch at any point can lead to disordered swallowing, known as dysphagia. A study backed by NIH's National Institute of Dental and Craniofacial Research imaged monkeys swallowing (as seen in this reconstructed video), revealing surprising new information that challenges current thinking about how swallowing happens. The insights could lead to better therapies for dysphagia. Learn more: https://go.usa.gov/xfCnQ #NIH #NIDCR #dysphagia

A post shared by NIH (@nihgov) on Jul 9, 2020 at 2:52pm PDT

View this post on Instagram

Are you interested in volunteering for a COVID-19 Clinical Study? The COVID-19 Prevention Network (CoVPN) is conducting studies to find safe and effective vaccines and monoclonal antibodies for the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), which is the virus that causes COVID-19. To volunteer, take the questionnaire to join the CoVPN Volunteer Screening Registry and you may be contacted if trials open up in your area: https://bit.ly/3faZL0v (follow link in bio) #COVID19 #SARSCoV2 #vaccinestudy #clinicalstudy

A post shared by NIH (@nihgov) on Jul 9, 2020 at 1:09pm PDT

View this post on Instagram

This high-resolution micrograph depicts a common primate kidney cell line (green) infected with SARS-CoV-2, the novel coronavirus that causes COVID-19. Notice the bulging, spherical cellular blebs, seen best in the upper right and bottom left corners. These badly damaged cells, which are filled to the point of bursting with viral particles, are beginning to self-destruct. Some cells have apparently already burst open, allowing hundreds of viral particles (purple) to spill out and potentially infect other cells. ⠀ By studying 3D images, researchers can learn about things such as the rate of infection and the prodigious number of particles each infected cell produces. They can also learn about how the infection affects the conditions inside cells.⠀ This stunning picture was taken by John Bernbaum, an electron microscopist with NIH's National Institute of Allergy and Infectious Diseases (@niaid). Read more about his work and the science depicted in the image on the NIH Director's Blog: directorsblog.nih.gov (or follow link in bio)⠀ #NIH #NIAID #coronavirus #COVID19 #scienceimage #virus #cells #microscopy

A post shared by NIH (@nihgov) on Jul 7, 2020 at 6:34pm PDT

View this post on Instagram

Repost from @irpatnih: This 3D image of a mouse intestine shows different proteins in the organ labeled with differently colored antibodies: green, red, yellow, and purple. Taking pictures like this one — whether of individuals cells, organs, or entire microorganisms — can produce invaluable insights about the structure of cells and tissues and the ways they behave. However, producing these sorts of highly complex images requires the processing of huge amounts of data, which can take weeks or months. ⠀⠀⠀ #NIH researchers and their collaborators at @uchicago and China's Zhejiang University recently developed new image processing techniques for #microscopes that can reduce post-processing time up to several thousand-fold, making it much easier to produce high-quality images of microscopic samples. ⠀⠀⠀ Read more about the new image processing method by following the link in bio.⠀ #NIH #NIBIB #microscopy #scienceimage #sciencefriday

A post shared by NIH (@nihgov) on Jul 3, 2020 at 1:50pm PDT